MARKER THERAPEUTICS, INC. Operating Lease Right-of-Use Assets
MARKER THERAPEUTICS, INC. (MRKR) had Operating Lease Right-of-Use Assets of $5.33 million as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2023-05-15
- 2023-03-31: Operating Lease, Right-of-Use Asset $5.33M.
- 2022-12-31: Operating Lease, Right-of-Use Asset $5.48M.
- 2022-09-30: Operating Lease, Right-of-Use Asset $5.63M.
- 2022-06-30: Operating Lease, Right-of-Use Asset $9.30M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-03-31 | $5.33M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $5.48M 10-Q · filed 2023-05-15 |
| 2022-09-30 | $5.63M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $9.30M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $9.57M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $9.83M 10-K · filed 2023-03-22 |
| 2021-09-30 | $10.09M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $10.34M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $10.59M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $10.84M 10-K · filed 2022-03-17 |
| 2020-09-30 | $11.06M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $9.54M 10-Q · filed 2020-08-10 |
| 2020-06-26 | $200.00K 10-Q · filed 2020-11-09 |
| 2020-03-31 | $407.81K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $455.17K 10-K · filed 2021-03-09 |
| 2019-09-30 | $501.71K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $547.46K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $592.42K 10-Q · filed 2019-05-10 |
| 2019-01-01 | $637.00K 10-K · filed 2020-03-12 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |